San Diego Stock Exchange

SEARCH SAN DIEGO STOCKS:

Symbol

ARENA PHARMACEUTICALS INC

Symbol	Name	Close	Change		Volume	Dayhigh	Daylow
ARNA	Arena Pharma	7.43	0.09	+ 1.23%	8833311.00	7.55	7.34

Exchange	Earningspershare	52-Week High	52-Week Low
NASDAQ N-Mkt	-1.82	8.00	2.70

SourceBook Information

Arena Pharmaceuticals Inc. is listed in:

• Biomed & Biotech Firms -
• Biomed & Biotech Firms - Publicly Traded -
• Highest Paid CEOs of BIO Tech Companies -
• Local Publicly Traded Companies -

Contact Information

Company Name

Arena Pharmaceuticals Inc.

Executives

Jack Lief, President, CEO/Director

Steven Spector, Sr. VP/Counsel/Secy

Robert Hoffman, VP, Finance

Louis J. Scotti, VP, Business Development & Marketing

Dominic Behan, Co-Founder, Director

Address

6166 Nancy Ridge Drive

San Diego, CA 92121

Phone

(858) 453-7200

Fax

(858) 453-7210

E-mail

invest@arenapharm.com

Web Page

www.arenapharm.com

Business Information

Parent Company

n/a

SIC Code

2834

Headquarters

San Diego, CA

Local Mailing Address

6166 Nancy Ridge Drive, San Diego, CA 92121

Year Established

1997

Year Established in San Diego

1997

Publicly Traded?

Yes

Ticker Symbol

ARNA

Total Number of Employees

291

Number of Local Employees

195

Number of Offices Local

n/a

Gross Revenue 2003 Year End

$13,000,000

Business Description

A recognized world leader in GPCR drug discovery and development across all major therapeutic areas. Continuing to foster and environment of scientific excellence and innovation.

Gross Revenue 2002 Year End

n/a

Business Services

Clinial-stage biopharmaceuticals

Industries of Interest

Biotechnology/Drugs

Market Capitalization

$320,889,300

Gross Revenue 2000

$7,683,396

Gross Revenue 2000 Year End

N/A

Gross Revenue 2001

$18,059,999

Gross Revenue 2001 Year End

N/A

Gross Revenue 2002

$19,421,765

Gross Revenue 2003

$12,834,279

Gross Revenue 2004

$14,000,000

Gross Revenue 2005 YTD, Local

n/a

Gross Revenue 2007

n/a

Gross Revenue 2009

n/a

Gross Revenue 2010

n/a

Manufacturer

No

Fields of Research

G protein-coupled receptors.

Major Products

Drug discovery and development

Major Investors

n/a

Number of Products Approved For Sale

0

Patents

n/a

Number of Products In Development

2

Strategic Alliances

Merck, Fujisawa, Taisho, Taigan

Services Offered

n/a

Chief Executive Officer

Jack Lief

Date CEO Began

1997

Total Annual CEO Compensation (salary & bonuses)

$654,000 (FY 2004)

CEO Salary

$604,000 (FY 2004)

CEO Bonuses

$50,000 (FY 2004)

Gross Revenue 2006

n/a

Sales for 2006

n/a

Gross Revenue 2008

n/a

Mission Statement

n/a